Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 5/2018

01-05-2018 | Erratum

Erratum to: Factors Associated with Mood Disorder Diagnosis Among a Population Based Cohort of Men and Women Living With and Without HIV in British Columbia Between 1998 and 2012

Authors: Kalysha Closson, Chuck Osborne, Danielle M. Smith, Sarah Kesselring, Oghenowede Eyawo, Kiffer Card, Paul Sereda, Shahab Jabbari, Conrado Franco-Villalobos, Tareq Ahmed, Karyn Gabler, Thomas Patterson, Mark Hull, Julio S. G. Montaner, Robert S. Hogg, for The Comparative Outcomes and Services utilization Trends (COAST) study

Published in: AIDS and Behavior | Issue 5/2018

Login to get access

Excerpt

The original version of this article omitted a reference entry and the applicable citation. The missing reference is given below. The citation should be placed next to the text “and derived from Population Data BC hospitalization, medical service plan (MSP), vital statistics and PharmaNet datasets within the COAST study [20–24] (refer to Table 1).” in the ‘Outcome and Explanatory Variables’ subsection of the Methods’ section of the original article. …
Metadata
Title
Erratum to: Factors Associated with Mood Disorder Diagnosis Among a Population Based Cohort of Men and Women Living With and Without HIV in British Columbia Between 1998 and 2012
Authors
Kalysha Closson
Chuck Osborne
Danielle M. Smith
Sarah Kesselring
Oghenowede Eyawo
Kiffer Card
Paul Sereda
Shahab Jabbari
Conrado Franco-Villalobos
Tareq Ahmed
Karyn Gabler
Thomas Patterson
Mark Hull
Julio S. G. Montaner
Robert S. Hogg
for The Comparative Outcomes and Services utilization Trends (COAST) study
Publication date
01-05-2018
Publisher
Springer US
Published in
AIDS and Behavior / Issue 5/2018
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-017-1858-7

Other articles of this Issue 5/2018

AIDS and Behavior 5/2018 Go to the issue

Original Paper

Multicenter European Prevalence Study of Neurocognitive Impairment and Associated Factors in HIV Positive Patients

Original Paper

Memory Impairment in HIV-Infected Individuals with Early and Late Initiation of Regular Marijuana Use

Original Paper

A Longitudinal Analysis of the Impact of Physical Activity on Neurocognitive Functioning Among HIV-Infected Adults

Original Paper

Disclosure and Stigma of a Positive HIV-Serostatus: A Two-Step Cluster Analysis of the HIV Disclosure Scale

Substantive Review

Measurements of Sexuality-Based Stigma among Gay, Bisexual, and Other Men Who Have Sex with Men (GBMSM) in Resource-Poor Settings: A Review

Original Paper

Changes in Anxiety and Depression Symptoms Predict Sexual Risk Behaviors Among Young Men Living in Dar es Salaam, Tanzania
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits